Income Taxes (Tables)

12 Months Ended

Dec. 31, 2023

Income Tax Disclosure [Abstract]

Schedule of Loss Before Income Taxes

The components of the Company's loss before income taxes for the years ended December 31, 2023, 2022, and 2021 were as follows:

	Year Ended December 31,
	2023		2022		2021
	(in thousands)
Domestic	$	(210,547)	$	(219,586)	$	(272,995)
Foreign	32,685		28,853		25,019
Total loss before income taxes	$	(177,862)	$	(190,733)	$	(247,976)

Schedule of Provision for (Benefit From) Income Taxes

The components of the Company's provision for (benefit from) income taxes for the years ended December 31, 2023, 2022, and 2021 were as follows:

	Year Ended December 31,
	2023		2022		2021
	(in thousands)
Current expense:
Federal	$	513	$	332	$	722
State	324		1		143
Foreign	2,986		2,455		2,730
Total current provision for income taxes	$	3,823	$	2,788	$	3,595
Deferred expense (benefit):
Federal	—		(1,124)		—
State	—		(573)		—
Foreign	2,264		1,557		8,738
Total deferred provision for (benefit from) income taxes	$	2,264	$	(140)	$	8,738
Total provision for income taxes	$	6,087	$	2,648	$	12,333

Schedule of Reconciliation of U.S. Federal Statutory Rate to Effective Tax Rate

A reconciliation of the U.S. federal statutory rate to the Company's effective tax rate is as follows:

	Year Ended December 31,
	2023		2022		2021
Expected benefit at U.S. federal statutory rate	21.0	%	21.0	%	21.0	%
State income taxes, net of federal tax benefits	(0.1)		0.2		—
Foreign income or losses taxed at different rates	1.0		1.1		(2.5)
Stock-based compensation	12.4		18.7		43.6
Change in valuation allowance	(30.6)		(41.2)		(66.4)
Withholding taxes	(0.3)		(0.2)		(0.3)
Gain/loss on convertible senior notes	(5.1)		—		(0.4)
Miscellaneous permanent items	(1.7)		(1.0)		—
Total provision for income taxes	(3.4)	%	(1.4)	%	(5.0)	%

Schedule of Deferred Tax Assets and Liabilities

The components of the Company's deferred tax assets and liabilities as of December 31, 2023 and 2022 were as follows:

	Year Ended December 31,
	2023		2022
	(in thousands)
Deferred tax assets:
Net operating loss carryforwards	$	390,405	$	373,655
Tax credit carryforwards	65,390		51,925
Capitalized research and development expenditures	71,617		36,886
Operating lease liabilities	36,609		33,790
Business interest carryforwards	1,244		15,762
Stock-based compensation	35,786		27,766
Accrued expenses and reserves	4,650		2,770
Capitalized contract expenditures	32,425		—
Depreciation and amortization	129		3
Other	2,106		919
Gross deferred tax assets	640,361		543,476
Valuation allowance	(552,165)		(477,638)
Total deferred tax assets	$	88,196	$	65,838
Deferred tax liabilities:
Right-of-use assets	(33,337)		(31,586)
Deferred commissions	(32,807)		(23,039)
Capitalized internal-use software	(3,909)		(4,638)
Depreciation and amortization	(25,045)		(11,197)
Other	(57)		(73)
Total deferred tax liabilities	$	(95,155)	$	(70,533)
Net deferred tax liabilities	$	(6,959)	$	(4,695)

Schedule of Reconciliation of Gross Unrecognized Tax Benefits

A reconciliation of the beginning and ending amount of the Company's total gross unrecognized tax benefits was as follows:

	Year Ended December 31,
	2023		2022		2021
	(in thousands)
Balance as of the beginning of the period	$	23,940	$	12,590	$	5,682
Increases for tax positions related to the prior year	590		5,753		1,784
Decreases for tax positions related to the prior year	(243)		—		—
Additions for tax positions related to the current year	4,752		5,597		5,124
Balance as of the end of the period	$	29,039	$	23,940	$	12,590